Literature DB >> 17050887

Surviving sepsis--practice guidelines, marketing campaigns, and Eli Lilly.

Peter Q Eichacker1, Charles Natanson, Robert L Danner.   

Abstract

Mesh:

Substances:

Year:  2006        PMID: 17050887     DOI: 10.1056/NEJMp068197

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  55 in total

1.  [Science defeats politics and commerce].

Authors:  V Dörges
Journal:  Anaesthesist       Date:  2010-12       Impact factor: 1.041

2.  Results from the National Sepsis Practice Survey: use of drotrecogin α (activated) and other therapeutic decisions.

Authors:  James M O'Brien; Scott K Aberegg; Naeem A Ali; Gregory B Diette; Stanley Lemeshow
Journal:  J Crit Care       Date:  2010-06-19       Impact factor: 3.425

3.  The Surviving Sepsis Campaign's Revised Sepsis Bundles.

Authors:  Amisha V Barochia; Xizhong Cui; Peter Q Eichacker
Journal:  Curr Infect Dis Rep       Date:  2013-10       Impact factor: 3.725

4.  The European Society of Intensive Care Medicine (ESICM) and the Surviving Sepsis Campaign (SSC).

Authors:  V Marco Ranieri; Rui P Moreno; Andy Rhodes
Journal:  Intensive Care Med       Date:  2007-02-16       Impact factor: 17.440

5.  Recombinant human activated protein C in experimental models of acute lung injury: the timing is critical!

Authors:  Corinna Velik-Salchner; Volker Wenzel; Dirk M Maybauer; Marc O Maybauer
Journal:  Intensive Care Med       Date:  2007-08-02       Impact factor: 17.440

6.  [Endogenous anticoagulant therapy for sepsis. Success and failure].

Authors:  C J Wiedermann
Journal:  Internist (Berl)       Date:  2007-05       Impact factor: 0.743

7.  [Update of the Surviving Sepsis Campaign guidelines 2008].

Authors:  J Briegel
Journal:  Anaesthesist       Date:  2008-03       Impact factor: 1.041

Review 8.  Low-tidal-volume ventilation in the acute respiratory distress syndrome.

Authors:  Atul Malhotra
Journal:  N Engl J Med       Date:  2007-09-13       Impact factor: 91.245

9.  [Therapeutic hypothermia after cardiopulmonary resuscitation - pro and con].

Authors:  Christoph Pechlaner; Michael Joannidis
Journal:  Wien Med Wochenschr       Date:  2008

10.  The Surviving Sepsis Campaign: robust evaluation and high-quality primary research is still needed.

Authors:  Simon Finfer
Journal:  Intensive Care Med       Date:  2010-01-13       Impact factor: 17.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.